Zini Tanzi, Gina
 Distribuzione geografica
Continente #
EU - Europa 5.360
NA - Nord America 4.939
AS - Asia 3.472
SA - Sud America 690
AF - Africa 101
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.578
Nazione #
US - Stati Uniti d'America 4.795
DE - Germania 1.794
SG - Singapore 1.467
IT - Italia 1.335
CN - Cina 909
BR - Brasile 561
SE - Svezia 530
VN - Vietnam 359
FR - Francia 356
GB - Regno Unito 304
UA - Ucraina 291
IE - Irlanda 164
IN - India 142
ID - Indonesia 140
PL - Polonia 137
FI - Finlandia 135
RU - Federazione Russa 74
JP - Giappone 73
HK - Hong Kong 68
CA - Canada 65
NL - Olanda 65
TR - Turchia 54
AR - Argentina 52
MX - Messico 46
BE - Belgio 40
IQ - Iraq 37
BD - Bangladesh 35
PK - Pakistan 23
ZA - Sudafrica 23
ES - Italia 21
AT - Austria 19
EC - Ecuador 19
IR - Iran 18
PE - Perù 16
SA - Arabia Saudita 16
CO - Colombia 14
LT - Lituania 14
MA - Marocco 14
CI - Costa d'Avorio 13
MY - Malesia 13
PT - Portogallo 13
CH - Svizzera 12
IL - Israele 12
PH - Filippine 12
AU - Australia 11
JO - Giordania 11
KE - Kenya 11
AE - Emirati Arabi Uniti 10
KR - Corea 10
CZ - Repubblica Ceca 9
UZ - Uzbekistan 9
VE - Venezuela 9
RO - Romania 8
DZ - Algeria 7
EG - Egitto 7
CL - Cile 6
GE - Georgia 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
EE - Estonia 5
GR - Grecia 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LB - Libano 5
PY - Paraguay 5
YE - Yemen 5
BH - Bahrain 4
CR - Costa Rica 4
DK - Danimarca 4
ET - Etiopia 4
JM - Giamaica 4
NG - Nigeria 4
NO - Norvegia 4
PA - Panama 4
QA - Qatar 4
TW - Taiwan 4
AM - Armenia 3
AO - Angola 3
BG - Bulgaria 3
BZ - Belize 3
HN - Honduras 3
LV - Lettonia 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BO - Bolivia 2
BY - Bielorussia 2
GH - Ghana 2
LK - Sri Lanka 2
LY - Libia 2
MK - Macedonia 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
AD - Andorra 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
Totale 14.554
Città #
Singapore 736
Chandler 647
Ashburn 463
San Jose 380
Beijing 199
Jacksonville 195
San Mateo 174
Ann Arbor 169
Dublin 163
Milan 154
Dearborn 148
Nanjing 144
Rome 140
Los Angeles 131
Warsaw 114
Jakarta 112
Hanoi 107
Nürnberg 105
Ho Chi Minh City 104
New York 89
Lauterbourg 87
Munich 83
Woodbridge 82
Cattolica 81
Dallas 81
Wilmington 78
Frankfurt am Main 72
Boston 71
Lawrence 66
Redmond 60
Tokyo 60
Houston 59
Fairfield 58
Seattle 58
Bremen 55
The Dalles 54
Hong Kong 53
Nanchang 53
São Paulo 52
Redwood City 50
Hefei 49
Marseille 49
Lancaster 47
Moscow 39
Brussels 38
Helsinki 36
Naples 36
Hangzhou 35
Santa Clara 33
London 31
Izmir 29
Paris 29
Norwalk 27
Chicago 25
Florence 25
Leawood 25
Mountain View 25
Princeton 25
Shenyang 25
Toronto 25
Boardman 24
Rio de Janeiro 24
Zhengzhou 24
Buffalo 23
Turin 23
Da Nang 22
Kunming 22
Shanghai 22
Tianjin 22
Brooklyn 20
Turku 20
Cagliari 19
Guangzhou 19
Jiaxing 19
Palermo 19
Bologna 18
Augusta 17
Baghdad 17
Columbus 17
Hebei 17
Montreal 17
Orem 17
Düsseldorf 16
Pune 16
Haiphong 15
Mexico City 15
San Francisco 15
Cambridge 14
Falls Church 14
Hyderabad 14
University Park 14
Abidjan 13
Chennai 13
Genoa 13
Johannesburg 13
Vienna 13
Bari 12
Brasília 12
Lima 12
Mumbai 12
Totale 7.128
Nome #
MORFOLOGIA DELLE MALATTIE DEL SANGUE Verduci Editore 1.121
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 371
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 365
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD 337
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 295
ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features 289
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 287
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 235
Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants 225
Allogeneic umbilical cord blood red cell concentrates: an innovative blood product for transfusion therapy of preterm infants 217
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 209
Defective WNT Signaling and Genetic Profile Of Endothelial Cells In Patients With Low Risk Myelodysplastic Syndromes Suggest a Contribution Of Vascular Niches To Myelodysplasia 209
Weak D Type 4.2.2 (DAR1.2) in an African child: Serology and molecular characterization 198
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 197
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 194
Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors 192
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 187
Morphology of Blood Disorders 181
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 180
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 180
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 179
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 178
Hypoxia-inducible factor-1α(Pro-582-Ser) polymorphism prevents iron deprivation in healthy blood donors 177
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 174
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 172
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 172
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases 170
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 164
Allogeneic umbilical cord blood red cell concentrates: An innovative blood product for transfusion therapy of preterm infants 163
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 157
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 156
Transfusion of very low birth weight neonates using allogeneic cord blood derived RBC units. 155
TWO-GROUP STUDY OF MEDIAL MICROSCOPY AS A ROBUST TOOL TO HARMONIZE AND STANDARDIZE HAEMATOLOGICAL DIAGNOSIS 155
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 153
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 153
The role of molecular typing and perfect match transfusion in sickle cell disease and thalassaemia: An innovative transfusion strategy 151
Analysis of bone marrow aspiration fluid using automated blood cell counters. 150
Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria. 148
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 143
Allogeneic cord blood red cells for transfusion 143
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 139
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 138
Increased levels of solubile intercellular adhesion molecole-1, neutrophils and elastase in the lung of preterm infants with bronchopulmonary displasia. 134
Primary myelofibrosis: when the clone manifests with Rh phenotype splitting 131
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 131
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 131
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 130
Poor mobilizer: a retrospective study on proven and predicted incidence according to GITMO criteria 128
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 127
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up: The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 125
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 124
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study 120
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 120
ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes 119
Fechtner syndrome: report of a third family and literature review 118
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 115
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 115
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 113
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 112
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 112
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial 111
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 111
the concomitance of lymphoma and breast carcinoma in the bone 111
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 107
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 105
Medicine use in pregnancy and public cord blood bank databases 104
2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions 103
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization? 101
Inline extracorporeal photopheresis: evaluation of cell collection efficiency 100
Leukemia diagnosis: today and tomorrow 99
Fragmented red blood cells automated measurement is a useful parameter to exclude schistocytes on the blood film 98
Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas 98
Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes? 97
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 95
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 93
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 92
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance 90
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 88
The concomitance of lymphoma and breast carcinoma in the bone 88
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 87
Diagnostics and prognostication of myelodysplastic syndromes 86
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 85
Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia 85
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 84
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets 83
CELL-BY-CELL ASSESSMENT OF MEDIAL MICROSCOPY (MM) AS A BETWEEN-OBSERVER TOOL FOR HARMONIZATION AND PROFICIENCY TESTING (ON BEHALF OF WP10 LEUKEMIANET DIAGNOSIS MORPHOLOGICAL FACULTY) 81
Innovation in hematology: Morphology and flow cytometry at the crossroads 77
Case of metastatic melanoma in bone marrow smear 76
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 76
Four cases of transfusion-transmitted Hepatitis E virus infection: Is it time to introduce donor screening in Italy? 73
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 68
Morphology and immunophenotyping issues in the integrated diagnosis of hematologic disorders of elderly patients 67
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 67
Spontaneous resolution of “therapy-related myelodysplasia” occurred after treatment with CAR-T cells: All that glitters is not gold 65
ICSH: on board for new projects 65
Schistocytes 65
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 64
INTRODUCTION 61
Research in morphology and flow cytometry is at the heart of hematology 58
Totale 14.728
Categoria #
all - tutte 52.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.257


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021195 0 0 0 0 0 0 0 0 0 29 157 9
2021/2022957 82 91 22 49 77 37 30 163 36 52 132 186
2022/20231.880 214 261 146 289 139 234 78 169 238 28 51 33
2023/2024970 55 253 33 64 48 142 86 26 23 37 105 98
2024/20252.075 45 72 150 100 222 98 98 99 281 208 402 300
2025/20264.174 721 136 268 409 702 245 843 229 288 333 0 0
Totale 14.728